MongoDB Inc. diskutieren
MongoDB, Inc. (NASDAQ: MDB) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $344.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating. They now have a $344.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) is now covered by analysts at China Renaissance. They set a "buy" rating and a $351.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Loop Capital from $400.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $350.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Morgan Stanley from $350.00 to $315.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Bank of America Co. from $420.00 to $286.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Needham & Company LLC from $415.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Robert W. Baird from $390.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Wedbush from $360.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Barclays PLC from $330.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Piper Sandler from $425.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Royal Bank of Canada from $400.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $400.00 to $330.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Truist Financial Co. from $400.00 to $300.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Stifel Nicolaus from $425.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $390.00 to $335.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at Truist Financial Co. from $300.00 to $275.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Ultragenyx Pharmaceutical Inc. diskutieren